Abstract
We have previously described (L. M. Vaughan, P. R. Smith, and T. J. Foster, Infect. Immun. 61:2172-2181, 1993) the construction of a kanamycin-resistant aromatic-dependent mutant of Aeromonas salmonicida, the causative agent of furunculosis, and its use as a live vaccine. Here we describe the construction of an unmarked aroA deletion mutant and examine the nature and magnitude of immune responses in rainbow trout (Oncorhynchus mykiss) to this vaccine strain. Good proliferative and antibody responses were elicited by using a range of vaccine doses from 2 x 10(6) to 2 x 10(9) live bacteria per fish, and a clear vaccine dose effect was apparent. A significant positive effect of using live bacteria to prime for lymphocyte proliferation and antibody production was apparent. However, the problem of directly comparing the vaccine doses of live and killed bacterial preparations is discussed, since some replication of live bacteria in vivo is expected. Most importantly, the live vaccine preferentially stimulated enhanced T-cell responsiveness, as evidenced by significantly greater increases in T-cell proliferation than in B-cell proliferation, compared with responses by the respective cell populations from fish given a killed vaccine. The manner in which live vaccines elicit strong cell-mediated immune responses and the relevance to fish vaccine design are discussed.
Full Text
The Full Text of this article is available as a PDF (325.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Garduño R. A., Thornton J. C., Kay W. W. Fate of the fish pathogen Aeromonas salmonicida in the peritoneal cavity of rainbow trout. Can J Microbiol. 1993 Nov;39(11):1051–1058. doi: 10.1139/m93-159. [DOI] [PubMed] [Google Scholar]
- Graham S., Secombes C. J. Cellular requirements for lymphokine secretion by rainbow trout Salmo gairdneri leucocytes. Dev Comp Immunol. 1990 Winter;14(1):59–68. doi: 10.1016/0145-305x(90)90008-3. [DOI] [PubMed] [Google Scholar]
- Izhar M., DeSilva L., Joysey H. S., Hormaeche C. E. Moderate immunodeficiency does not increase susceptibility to Salmonella typhimurium aroA live vaccines in mice. Infect Immun. 1990 Jul;58(7):2258–2261. doi: 10.1128/iai.58.7.2258-2261.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaufmann S. H. Immunity to intracellular microbial pathogens. Immunol Today. 1995 Jul;16(7):338–342. doi: 10.1016/0167-5699(95)80151-0. [DOI] [PubMed] [Google Scholar]
- Marsden M. J., Cox D., Secombes C. J. Antigen-induced release of macrophage activating factor from rainbow trout Oncorhynchus mykiss leucocytes. Vet Immunol Immunopathol. 1994 Aug;42(2):199–208. doi: 10.1016/0165-2427(94)90008-6. [DOI] [PubMed] [Google Scholar]
- Thatte J., Rath S., Bal V. Immunization with live versus killed Salmonella typhimurium leads to the generation of an IFN-gamma-dominant versus an IL-4-dominant immune response. Int Immunol. 1993 Nov;5(11):1431–1436. doi: 10.1093/intimm/5.11.1431. [DOI] [PubMed] [Google Scholar]
- Thornton J. C., Garduño R. A., Newman S. G., Kay W. W. Surface-disorganized, attenuated mutants of Aeromonas salmonicida as furunculosis live vaccines. Microb Pathog. 1991 Aug;11(2):85–99. doi: 10.1016/0882-4010(91)90002-r. [DOI] [PubMed] [Google Scholar]
- Vaughan L. M., Smith P. R., Foster T. J. An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis. Infect Immun. 1993 May;61(5):2172–2181. doi: 10.1128/iai.61.5.2172-2181.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]